The significant upregulation of immune cell markers CD3, CD45, CD8, and PD-L1 in the tumor compartments of patients responsive to ICIs highlights the vital role of T cell-mediated immunity, suggesting the presence of a ‘hot tumor’ phenotype. This evidence concerns the gene PTPRC and neoplasm.